Natera’s Signatera ctDNA test will determine study eligibility and treatment effectiveness in HR-positive, HER2-negative breast cancer patients.
Rose McNulty
Advertisement
Rose is an associate editorial director at The American Journal of Managed Care® (AJMC®).
She has a BA in journalism & media studies and Spanish from Rutgers University. You can connect with Rose on LinkedIn.
Articles by Rose McNulty
Research from the American Cancer Society suggests that more young people are being introduced to nicotine via e-cigarettes.
Advertisement
Advertisement
Advertisement
Trending on AJMC
1
Contributor: Engagement Is the Missing Link in Kidney Care—How Payers and Value-Based Partnerships Can Close the Gap
2
Different Communication of HIV Risk Affects PrEP Interest
3
Reactivating CCNA2 Gene Enables Adult Heart Cells to Regenerate
4
BPA Exposure Linked to 127 Million Global Metabolic Disease Cases
5
